Modulation of Macrophage Recruitment into Wounds by Monocyte Chemoattractant Protein-1
Overview
Authors
Affiliations
Previous studies suggest that normal wound repair requires the regulated production of monocyte and macrophage chemoattractants. The current study examines the role of monocyte chemoattractant protein-1 (MCP-1) in coordinating monocyte recruitment into sites of injury. MCP-1 protein was detected in both incisional and excisional murine wounds, with a peak concentration occurring slightly before maximum macrophage infiltration. Compared to wounds treated with control antibody, wounds treated with a neutralizing monoclonal anti-MCP-1 antibody contained significantly fewer macrophages (8.2 +/- 0.9 vs. 14 +/- 1.7 macrophages per high power field, p < 0.05). Conversely, the addition of recombinant MCP-1 to wounds resulted in a substantial increase in the number of macrophages (107% to 124% increase over untreated wounds, p < 0.01). Because macrophages promote wound healing, the effect of recombinant MCP-1 on the wound healing process was examined. Incisional wounds (n = 12) were either left untreated or treated with vehicle alone, 5 ng recombinant MCP-1 in vehicle, or 50 ng recombinant MCP-1 in vehicle. Wound disruption strength was determined on days 7, 14, 21, and 28 for each group. Wounds treated with MCP-1 exhibited a slight increase in wound disruption strength at nearly all time points but this increase did not reach statistical significance. Addition of 100 ng of MCP-1 to excisional wounds did not have any significant effect on wound reepithelialization. Taken together, the results show that MCP-1 is produced within wounds at physiologic concentrations, and is an important positive regulator of macrophage recruitment into sites of injury. Addition of exogenous MCP-1 to wounds of normal mice yields only modest enhancement of the repair process.
Faghani G, Azarniya A Heliyon. 2024; 10(21):e39611.
PMID: 39524817 PMC: 11550055. DOI: 10.1016/j.heliyon.2024.e39611.
Shahin H, Belcastro L, Das J, Perdiki Grigoriadi M, Saager R, Steinvall I Front Bioeng Biotechnol. 2024; 12:1328504.
PMID: 38562669 PMC: 10982420. DOI: 10.3389/fbioe.2024.1328504.
Jia Q, Zhao H, Wang Y, Cen Y, Zhang Z Front Immunol. 2023; 14:1214757.
PMID: 37520532 PMC: 10376705. DOI: 10.3389/fimmu.2023.1214757.
Blackstone B, Malara M, Baumann M, McFarland K, Supp D, Powell H Bioengineering (Basel). 2023; 10(7).
PMID: 37508888 PMC: 10376754. DOI: 10.3390/bioengineering10070861.
Yao H, Yuan X, Wu Z, Park S, Zhang W, Chong H Int J Mol Sci. 2023; 24(2).
PMID: 36674754 PMC: 9867201. DOI: 10.3390/ijms24021240.